Beijing Tong Ren Tang Chinese Medicine Company Limited Stock Deutsche Boerse AG
Equities
TQR
HK0000145638
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 EUR | -0.88% | -5.83% | -18.71% |
Sales 2024 * | 1.74B 222M 205M | Sales 2025 * | 1.99B 255M 235M | Capitalization | 8.09B 1.04B 955M |
---|---|---|---|---|---|
Net income 2024 * | 652M 83.46M 76.94M | Net income 2025 * | 758M 97.03M 89.45M | EV / Sales 2024 * | 3.03 x |
Net cash position 2024 * | 2.83B 363M 334M | Net cash position 2025 * | 2.63B 337M 311M | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
9.64
x | Employees | 798 |
Yield 2024 * |
4.14% | Yield 2025 * |
4.81% | Free-Float | 28.23% |
1 day | -0.88% | ||
1 week | -5.83% | ||
Current month | -1.74% | ||
1 month | +5.61% | ||
3 months | +0.89% | ||
6 months | -25.17% | ||
Current year | -18.71% |
Managers | Title | Age | Since |
---|---|---|---|
Fung Yi Tsang
DFI | Director of Finance/CFO | 48 | 12-09-30 |
Xia Li
CTO | Chief Tech/Sci/R&D Officer | 54 | 07-12-31 |
Fei Chen
BRD | Director/Board Member | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ngai Chi Chan
BRD | Director/Board Member | 52 | 13-04-14 |
Hai Ou Gu
CHM | Chairman | 58 | Dec. 12 |
Yok Sing Tsang
BRD | Director/Board Member | 76 | 17-09-11 |
Date | Price | Change |
---|---|---|
24-05-24 | 1.13 | -0.88% |
24-05-23 | 1.14 | -3.39% |
24-05-22 | 1.18 | +2.61% |
24-05-21 | 1.15 | -3.36% |
24-05-20 | 1.19 | 0.00% |
Delayed Quote Deutsche Boerse AG, May 24, 2024 at 02:14 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- 3613 Stock
- TQR Stock